DR. NATHAN SHUMWAY D.O. FACP NPI 1285616359

NPI Information

  • NPI: 1285616359
  • Provider Name: DR. NATHAN SHUMWAY, D.O., FACP
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 18707 HARDY OAK BLVD
    SUITE 320
    SAN ANTONIO, TX
    ZIP 78258
  • Phone: (210) 545-6972

Map and Directions

Get Directions

NPI Details

DR. Nathan Shumway, D.O., FACP is a hematology and oncology internal medicine in San Antonio, TX with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Nathan Shumway, D.O., FACP NPI is 1285616359. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WESTERN UNIVERSITY OF HEALTH SCIENCES COLLEGE OF DENTAL MED
Graduation Year:2002

The provider's business location address is:

18707 HARDY OAK BLVD
SUITE 320
SAN ANTONIO, TX
ZIP 78258-791
Phone: (210) 545-6972
Fax: (210) 545-1016

The NPI 1285616359 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, daratumumab, 10 mg (HCPCS:J9145)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Blood test, clotting time (HCPCS:85610)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Folic acid level, serum (HCPCS:82746)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Unclassified drugs (HCPCS:J3490)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 11/15/2005 and was last updated on 1/28/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyDOS-1014HAWAIINo
2207RH0003XInternal MedicineHematology & OncologyP2528TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1P01547652OTHERTEXASRAILROAD MEDICARE
2349764601MEDICAIDTEXAS
3435183YKYCMEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.